Newborn Screening Awareness-September

Author: Turacoz Group
September 17, 2015

Newborn screening test (also known as Guthrie test) is one of the successful innovations in the modern era. It is a procedure where in the newborn infants are pricked at the heel to test their blood for rare genetic, endocrine and metabolic conditions that can be harmful or serious. Also tested for hearing loss before discharge from the hospital. These screening tests has the potential to identify risk of certain diseases before the clinical symptoms appear. Thus, early detection and treatment can prevent mental retardation, spasticity, serious illness, and premature death.

According to World Health Organization (WHO), every year 140 million children are born and out of which 5 million die in the first month of life in developing countries. Four percent of the India population are mentally retarded and 5-15% of sick newborns are thought to have a metabolic problem.

Disorders which can be detected through Newborn Screening test,

  • Biotinidase deficiency
  • Congenital adrenal hyperplasia
  • Congenital primary hypothyroidism
  • G6PD deficiency
  • Cystic fibrosis
  • Galactosemia
  • Disorders of amino acids, organic acids and fatty acid oxidation by tandem mass spectroscopy
  • Sickle cell anemia

To avoid these anomalies which are hidden at birth, many non-profit organizations are developed taking care of all the newborn screening tests. The main goal of these organizations are to educate the parents, paediatric healthcare workers, lawmakers, and institutional policymakers. Also the educational programs accentuate the importance of newborn screening through comprehensive testing to identify disorders and initiate treatment promptly when necessary.

There are many campaigns like the “Be Bold, Wear Gold Campaign” to create awareness into the public regarding the newborn screening tests. In the month of September, the newborn screening community (which includes families, advocates, state health departments, legislators, and state laboratories) rallied around the principle that all babies deserve a healthy start. As a support to the campaign, members of the community wear a color gold and gold pins throughout the month.

To avoid such serious diseases and save the newborns spread the information (mouth publicity) about the screening test to all the members of your family, friends, colleagues etc. Mass education, media propagation, and training centres also can raise the awareness. Along with these share the stories you know and spread the awareness in the individuals wherein one can keep their newborns happy and safe.

 

You Might Also Like

  • Top Benefits of Using Academic Research Writing Services

    “Write the paper as though no editor will ever see it … then let a good editor make sure everyone

  • World Thyroid Day 2025: How AI Is Revolutionizing Thyroid Health

    World Thyroid Day invites us to appreciate the tiny, butterfly-shaped gland with a big job in managing our body’s energy,

  • How AI is redefining content creation in pharma — And why humans are still the drivers of trust

    In an era where speed, efficiency, and personalization have become imperatives, Artificial Intelligence (AI) — particularly machine learning, AI algorithms,

  • World Thalassemia Day 2025: Giving a Voice to the Global Patient Community

    Every 8 May, World Thalassemia Day shines an international spotlight on the millions of people living with this inherited genetic disorder.

  • Decoding Ovarian Cancer Symptoms: Communicating the Silent Signs

    Ovarian cancer remains one of the most challenging gynaecologic malignancies, often referred to as a “silent killer” due to its subtle onset and late-stage diagnosis.1 In 2022, 324,603 women worldwide were diagnosed with ovarian cancer.

  • 4 Ways in Which HEOR is Transforming Healthcare with RWE

    The healthcare landscape is being reshaped at an unprecedented pace, powered by sophisticated data analytics, emerging technologies, and the escalating

  • The Role of HEOR in Payer Decisions to Switch from Originators to Biosimilars

    Biosimilars—biologic medicines that are highly similar to FDA-approved originator biologics—offer a cost-effective alternative without compromising clinical efficacy.1,2 Since the first

  • Content’s Industrial Revolution: Shaping the Future of Pharma

    Communications In a rapidly evolving digital ecosystem, the pharmaceutical industry’s relationship with content is undergoing a seismic shift. At the

  • Health Journalism: Combating Misinformation with Accuracy

    By Turacoz Healthcare Solutions | World Liver Day 2025 In a world where social media dominates wellness discussions, liver health

  • Patient Voices Matter: How Patient-reported Outcomes Are Redefining Market Access

    The healthcare industry is experiencing a paradigm shift as patient voices take center stage in drug development and approval processes.

Newsletter

Stay informed with the latest trends, insights, and updates in medical communications—download our newsletter now.

partner with us

Partner with Turacoz to bring science to life through strategic and evidence-based communication.

Partner with Us